Mass. lawmaker Auchincloss favors boosting U.S. biotech over targeting China
Start here
Rep. Jake Auchincloss (D-Mass.) told the STAT Summit in Boston that Congress should invest in domestic biotech rather than rely on protectionist policies against China, which he said hurts U.S. competitiveness. He plans to introduce a bill modeled on Australia's system, letting early-phase trials bypass pre-approval evaluation by the national regulator to speed U.S. research. He also criticized the FDA's National Priority Voucher program and OMB proposals to override peer review, and backed cracking down on PBM practices and reforming 340B.
Excerpted from statnews.com
Coverage timeline
Follow the coverage to see the different angles.
- statnews.comMass. lawmaker Auchincloss favors boosting U.S. biotech over targeting China
Rep. Jake Auchincloss (D-Mass.) told the STAT Summit in Boston that Congress should invest in domestic biotech rather than rely on protectionist policies against China, which he said hurts U.S. competitiveness. He plans to introduce a bill modeled on Australia's system, letting early-phase trials bypass pre-approval evaluation by the national regulator to speed U.S. research. He also criticized the FDA's National Priority Voucher program and OMB proposals to override peer review, and backed cracking down on PBM practices and reforming 340B.
Heat trend for this story
还没有足够的连续观测数据，暂不绘制趋势。